Medtronic Inc.has reported higher-than-expected second quarter earnings as sales of newer devices helped make up for an ongoing slump in its best-selling heart and spine implants.
Medtronic
Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
Today, Medtronic, Inc. announces two significant clinical trials related to medical device interventions for stroke.
Talent Stent Graft Shows Durable Performance in Patients with Abdominal Aortic Aneurysms
Through five years following initial implantation in an FDA-approved study, the Talent Abdominal Stent Graft from Medtronic, Inc., demonstrated durable safety and effectiveness in patients with abdominal aortic aneurysms.